Apolipoprotein B in cardiovascular risk assessment.
作者信息
Ahmad Maud, Sniderman Allan D, Hegele Robert A
机构信息
Schulich School of Medicine and Dentistry (Ahmad, Hegele), Western University, London, Ont.; Mike and Valeria Rosenbloom Centre for Cardiovascular Prevention, Department of Medicine (Sniderman), McGill University Health Centre, Montréal, Que.
出版信息
CMAJ. 2023 Aug 28;195(33):E1124. doi: 10.1503/cmaj.230048.
Abstract
摘要
相似文献
1
Apolipoprotein B in cardiovascular risk assessment.心血管风险评估中的载脂蛋白B
CMAJ. 2023 Aug 28;195(33):E1124. doi: 10.1503/cmaj.230048.
2
Non-HDL cholesterol, apolipoproteins A-I and B100, standard lipid measures, lipid ratios, and CRP as risk factors for cardiovascular disease in women.非高密度脂蛋白胆固醇、载脂蛋白A-I和B100、标准血脂指标、血脂比值以及C反应蛋白作为女性心血管疾病的危险因素。
JAMA. 2005 Jul 20;294(3):326-33. doi: 10.1001/jama.294.3.326.
3
Contribution of apolipoprotein estimations to cardiovascular risk assessment in women with endometriosis.载脂蛋白评估对子宫内膜异位症女性心血管风险评估的贡献。
J Biol Regul Homeost Agents. 2021 May-Jun;35(3):1195-1198. doi: 10.23812/21-207-L.
4
APOLIPOPROTEINS AND THEIR ASSOCIATION WITH CARDIOMETABOLIC RISK BIOMARKERS IN ADOLESCENTS.青少年中的载脂蛋白及其与心脏代谢风险生物标志物的关联
Nutr Hosp. 2015 Dec 1;32(6):2674-83. doi: 10.3305/nh.2015.32.6.9779.
5
Hair mercury is associated with dyslipidemia and cardiovascular risk: An anthropometric, biochemical and genetic cross-sectional study of Amazonian vulnerable populations.毛发汞与血脂异常和心血管风险相关：一项对亚马逊脆弱人群进行的人体测量学、生物化学和遗传学的横断面研究。
Environ Res. 2023 Jul 15;229:115971. doi: 10.1016/j.envres.2023.115971. Epub 2023 Apr 25.
6
Hyperlipidaemia and cardiovascular disease: apolipoprotein measurements and metabolic syndrome as predictors of cardiovascular risk.高脂血症与心血管疾病：载脂蛋白检测及代谢综合征作为心血管风险的预测指标
Curr Opin Lipidol. 2008 Dec;19(6):624-6. doi: 10.1097/MOL.0b013e328316c030.
7
[Apolipoproteins and assessment of cardiovascular risk].[载脂蛋白与心血管风险评估]
Aten Primaria. 1993 Jul-Aug;12(3):125-6.
8
9
Triglycerides and cardiovascular risk: Apolipoprotein B holds the key.甘油三酯与心血管风险：载脂蛋白B是关键。
Atherosclerosis. 2019 May;284:221-222. doi: 10.1016/j.atherosclerosis.2019.03.004. Epub 2019 Mar 21.
10
Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review.载脂蛋白B水平、APOB等位基因与普通人群缺血性心血管疾病风险：综述
Atherosclerosis. 2009 Sep;206(1):17-30. doi: 10.1016/j.atherosclerosis.2009.01.004. Epub 2009 Jan 15.
引用本文的文献
1
Higher blood lipid levels after the transition to menopause in two forager-horticulturalist populations.两个觅食-园艺人群绝经后血脂水平升高。
Evol Med Public Health. 2025 Jul 20;13(1):201-214. doi: 10.1093/emph/eoaf020. eCollection 2025.
2
Plasma apolipoprotein concentrations and occurrence of cardiovascular events in the general population: an exploratory analysis.普通人群血浆载脂蛋白浓度与心血管事件的发生：一项探索性分析。
Atheroscler Plus. 2025 May 8;60:35-42. doi: 10.1016/j.athplu.2025.04.003. eCollection 2025 Jun.
3
APOC1 knockdown induces apoptosis and decreases angiogenesis in diffuse large B-cell lymphoma cells through blocking the PI3K/AKT/mTOR pathway.载脂蛋白C1（APOC1）基因敲低通过阻断PI3K/AKT/mTOR信号通路诱导弥漫性大B细胞淋巴瘤细胞凋亡并减少血管生成。
Biomol Biomed. 2025 Apr 3;25(5):1205-1217. doi: 10.17305/bb.2024.11550.
4
Enhancing dementia prediction: A 19-year validation of the CAIDE risk score with insulin resistance and APOE ε4 integration in a population-based cohort.增强痴呆症预测：在一个基于人群的队列中对CAIDE风险评分进行19年验证，并纳入胰岛素抵抗和APOE ε4因素
J Prev Alzheimers Dis. 2025 Feb;12(2):100034. doi: 10.1016/j.tjpad.2024.100034. Epub 2025 Jan 1.
5
Statin Use and Hyperglycemia: Do Statins Cause Diabetes?他汀类药物的使用与高血糖：他汀类药物会引发糖尿病吗？
Curr Atheroscler Rep. 2024 Dec 19;27(1):18. doi: 10.1007/s11883-024-01266-8.
6
Differential distribution of plasma apoA-I and apoB levels and clinical significance of apoB/apoA-I ratio in ischemic stroke subtypes.缺血性卒中亚型中血浆载脂蛋白A-I和载脂蛋白B水平的差异分布及载脂蛋白B/载脂蛋白A-I比值的临床意义
Front Neurol. 2024 Jun 24;15:1398830. doi: 10.3389/fneur.2024.1398830. eCollection 2024.
7
The Impact of Metabolic and Bariatric Surgery on Apo B100 Levels in Individuals with high BMI: A Multi-Centric Prospective Cohort Study.代谢与减重手术对高体重指数个体载脂蛋白B100水平的影响：一项多中心前瞻性队列研究。
Obes Surg. 2024 Jul;34(7):2454-2466. doi: 10.1007/s11695-024-07258-6. Epub 2024 May 15.
8
Effect of Adding Apolipoprotein B Testing on the Prevalence of Dyslipidemia and Risk of Cardiovascular Disease in the Korean Adult Population.添加载脂蛋白B检测对韩国成年人群血脂异常患病率及心血管疾病风险的影响。
Metabolites. 2024 Mar 18;14(3):169. doi: 10.3390/metabo14030169.
本文引用的文献
1
Physiological Bases for the Superiority of Apolipoprotein B Over Low-Density Lipoprotein Cholesterol and Non-High-Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk.载脂蛋白 B 优于低密度脂蛋白胆固醇和非高密度脂蛋白胆固醇作为心血管风险标志物的生理基础。
J Am Heart Assoc. 2022 Oct 18;11(20):e025858. doi: 10.1161/JAHA.122.025858. Epub 2022 Oct 10.
2
Association of Apolipoprotein B-Containing Lipoproteins and Risk of Myocardial Infarction in Individuals With and Without Atherosclerosis: Distinguishing Between Particle Concentration, Type, and Content.载脂蛋白 B 脂蛋白与动脉粥样硬化个体和非动脉粥样硬化个体心肌梗死风险的关联：区分颗粒浓度、类型和含量。
JAMA Cardiol. 2022 Mar 1;7(3):250-256. doi: 10.1001/jamacardio.2021.5083.
3
2021 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in Adults.2021 加拿大心血管学会成人血脂异常管理指南：预防心血管疾病
Can J Cardiol. 2021 Aug;37(8):1129-1150. doi: 10.1016/j.cjca.2021.03.016. Epub 2021 Mar 26.
4
Discordance between Circulating Atherogenic Cholesterol Mass and Lipoprotein Particle Concentration in Relation to Future Coronary Events in Women.循环中致动脉粥样硬化胆固醇质量与脂蛋白颗粒浓度的不一致与女性未来冠心病事件的关系
Clin Chem. 2017 Apr;63(4):870-879. doi: 10.1373/clinchem.2016.264515. Epub 2017 Feb 7.
Zotero 插件